Haematology

2023

1. A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

   Frontiers in Oncology, Vol. 13

2. AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib

   Cancer Reports, Vol. 6, Núm. 10

3. Application of IPSET-Thrombosis in 1366 Patients Prospectively Followed from the Spanish Registry of Essential Thrombocythemia

   HemaSphere, Vol. 7, Núm. 8, pp. E936

4. Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program

   European Journal of Haematology, Vol. 111, Núm. 2, pp. 293-299

5. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

   Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

6. Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

   Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901

7. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

   Blood Cancer Journal, Vol. 13, Núm. 1

8. Expert opinion paper on the treatment of hemophilia a with emicizumab

   Hematology (Amsterdam, Netherlands), Vol. 28, Núm. 1, pp. 2166334

9. Galician Experience with Avatrombopag: Galician Thrombosis and Hemostasis Group

   Blood, Vol. 142, Núm. Supplement 1, pp. 5446-5446

10. Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

    Journal of Thrombosis and Haemostasis

11. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

    Microbiology spectrum, Vol. 11, Núm. 4, pp. e0067423

12. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

    Journal of Fungi, Vol. 9, Núm. 6

13. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)

    British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871

14. Impact of Antibacterial Prophylaxis on Morbidity-Mortality of Patients with Myeloid Neoplasms Treated with Non-Intensive Venetoclax Combinations

    Blood, Vol. 142, Núm. Supplement 1, pp. 4270-4270

15. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437

16. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

    HemaSphere, Vol. 7, Núm. 10, pp. E961

17. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

    HemaSphere, Vol. 7, Núm. 1, pp. E818

18. Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

    Cancers, Vol. 15, Núm. 2

19. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

20. Prediction of major bleeding events in 1381 patients with essential thrombocythemia

    International Journal of Hematology, Vol. 118, Núm. 5, pp. 589-595